Zhejiang Orient Gene Biotech Co., Ltd.SSE: 688298

Announcement on Carrying out Forward Foreign Exchange Trading Business in 2026

· Issued by Zhejiang Orient Gene Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

The purpose of this trading is to mitigate risks associated with currency fluctuations related to its international sales. The company will utilize its own funds for this trading, with a specified limit on the amount involved. The announcement outlines the necessary risk management measures and operational guidelines for these transactions.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Carrying out Forward Foreign Exchange Trading Business in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Orient Gene Biotech Co., Ltd. on 6ix

Earlier from Zhejiang Orient Gene Biotech

Later from Zhejiang Orient Gene Biotech

All Zhejiang Orient Gene Biotech news releases